These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37927156)

  • 1. Author reply to Letter to the Editor regarding 'Understanding subjective experience in psychedelic-assisted psychotherapy: The need for phenomenology'.
    Miceli McMillan R; Fernandez AV
    Aust N Z J Psychiatry; 2024 Jan; 58(1):93-94. PubMed ID: 37927156
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the editor regarding "Understanding subjective experience in psychedelic-assisted psychotherapy: The need for phenomenology".
    Ventura B
    Aust N Z J Psychiatry; 2024 Jan; 58(1):92-93. PubMed ID: 37767966
    [No Abstract]   [Full Text] [Related]  

  • 3. Understanding subjective experience in psychedelic-assisted psychotherapy: The need for phenomenology.
    Miceli McMillan R; Fernandez AV
    Aust N Z J Psychiatry; 2023 Jun; 57(6):783-788. PubMed ID: 36384307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?
    Majić T; Schmidt TT; Gallinat J
    J Psychopharmacol; 2015 Mar; 29(3):241-53. PubMed ID: 25670401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extrapharmacological Safety Topics in Psychedelic-Assisted Psychotherapy.
    Calder A; Hasler G
    JAMA Psychiatry; 2023 Aug; 80(8):761-762. PubMed ID: 37256606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy.
    Hendricks PS
    Int Rev Psychiatry; 2018 Aug; 30(4):331-342. PubMed ID: 30260256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors.
    Ponomarenko P; Seragnoli F; Calder A; Oehen P; Hasler G
    J Psychopharmacol; 2023 Jul; 37(7):660-678. PubMed ID: 36855289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychedelic-assisted psychotherapy: where is the psychotherapy research?
    Aday JS; Horton D; Fernandes-Osterhold G; O'Donovan A; Bradley ER; Rosen RC; Woolley JD
    Psychopharmacology (Berl); 2024 Aug; 241(8):1517-1526. PubMed ID: 38782821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychedelics, placebo effects, and set and setting: Insights from common factors theory of psychotherapy.
    Gukasyan N; Nayak SM
    Transcult Psychiatry; 2022 Oct; 59(5):652-664. PubMed ID: 33499762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychedelic-assisted psychotherapy for the treatment of major depression: a synthesis of phenomenological explanations.
    Miceli McMillan R; Jordens C
    Med Health Care Philos; 2022 Jun; 25(2):225-237. PubMed ID: 35064398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychedelic Group Therapy.
    Gasser P
    Curr Top Behav Neurosci; 2022; 56():23-34. PubMed ID: 35091980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. It is not and never has been just about the drug: The need to emphasise psychotherapy in psychedelic-assisted psychotherapy.
    Lakeman R; Ryan T; Emeleus M
    Int J Ment Health Nurs; 2023 Jun; 32(3):945-946. PubMed ID: 36994904
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological and Nonpharmacological Components of Psychedelic Treatments: The Whole is Not the Sum of the Parts.
    Bogenschutz MP
    Am J Psychiatry; 2024 Jan; 181(1):75. PubMed ID: 38161306
    [No Abstract]   [Full Text] [Related]  

  • 14. Psychedelics and Psychotherapy.
    Nayak S; Johnson MW
    Pharmacopsychiatry; 2021 Jul; 54(4):167-175. PubMed ID: 33285578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychedelics and Evidence-based Psychotherapy: A Systematic Review with Recommendations for Advancing Psychedelic Therapy Research.
    Leone L; McSpadden B; DeMarco A; Enten L; Kline R; Fonzo GA
    Psychiatr Clin North Am; 2024 Jun; 47(2):367-398. PubMed ID: 38724126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychotherapy and psychedelic drugs - Authors' reply.
    Cristea IA; Halvorsen JØ; Cosgrove L; Naudet F
    Lancet Psychiatry; 2023 Mar; 10(3):168. PubMed ID: 36804069
    [No Abstract]   [Full Text] [Related]  

  • 17. Importance of Integrating Spiritual, Existential, Religious, and Theological Components in Psychedelic-Assisted Therapies.
    Palitsky R; Kaplan DM; Peacock C; Zarrabi AJ; Maples-Keller JL; Grant GH; Dunlop BW; Raison CL
    JAMA Psychiatry; 2023 Jul; 80(7):743-749. PubMed ID: 37256584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychedelic-Assisted Therapy for Substance Use Disorders and Potential Mechanisms of Action.
    Rieser NM; Herdener M; Preller KH
    Curr Top Behav Neurosci; 2022; 56():187-211. PubMed ID: 34910289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compassionate use of psychedelics.
    Greif A; Šurkala M
    Med Health Care Philos; 2020 Sep; 23(3):485-496. PubMed ID: 32468195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why MDMA therapy for alcohol use disorder? And why now?
    Sessa B
    Neuropharmacology; 2018 Nov; 142():83-88. PubMed ID: 29126911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.